- Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study
Fanghui Zhao et al, 2023, Asia-Pacific Journal of Clinical Oncology CrossRef - The prevalence of human papillomavirus among women in northern Guangdong Province of China
Wenbo Huang et al, 2022, Scientific Reports CrossRef - Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020
Qianhui Wu et al, 2023, Human Vaccines & Immunotherapeutics CrossRef - Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
Chichao Xia et al, 2021, Cancers CrossRef - Prevalence of Candida albicans in High-Risk Human Papillomavirus-Positive Women: A Study in Diyarbakır Province, Turkey
Efdal Oktay Gultekin et al, 2023, Canadian Journal of Infectious Diseases and Medical Microbiology CrossRef - Prevalence and genotype distribution of HPV infection among women in Xiamen, China
Ye Shen et al, 2023, Frontiers in Microbiology CrossRef